64 related articles for article (PubMed ID: 21198273)
21. Association Between COX-2 Polymorphisms and Lung Cancer Risk.
Wang W; Fan X; Zhang Y; Yang Y; Yang S; Li G
Med Sci Monit; 2015 Dec; 21():3740-7. PubMed ID: 26624903
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects.
Li Y; Qiu LX; Shen XK; Lv XJ; Qian XP; Song Y
Lung Cancer; 2009 Oct; 66(1):15-21. PubMed ID: 19178978
[TBL] [Abstract][Full Text] [Related]
23. COX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis.
Wang XF; Huang MZ; Zhang XW; Hua RX; Guo WJ
PLoS One; 2013; 8(9):e73213. PubMed ID: 24023834
[TBL] [Abstract][Full Text] [Related]
24. Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer.
Tan X; Wang YY; Chen XY; Xian L; Guo JJ; Liang GB; Chen MW
Genet Mol Res; 2014 Sep; 13(3):7437-46. PubMed ID: 25222243
[TBL] [Abstract][Full Text] [Related]
25. Association between COX-2 polymorphisms and non-small cell lung cancer susceptibility.
Zhang T; Li J; Xia T; Zhang N; Zhang Y; Zhao J
Int J Clin Exp Pathol; 2015; 8(3):3168-73. PubMed ID: 26045835
[TBL] [Abstract][Full Text] [Related]
26. Genetic association between AGPHD1 variant and lung cancer risk.
Wang H; Liu ZD
Cell Biochem Biophys; 2014 Dec; 70(3):1963-8. PubMed ID: 25074529
[TBL] [Abstract][Full Text] [Related]
27. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 gene polymorphisms and risk of Alzheimer's disease: A meta-analysis.
Luo D; Long Y; Chen GJ
J Neurol Sci; 2015 Dec; 359(1-2):100-5. PubMed ID: 26671095
[TBL] [Abstract][Full Text] [Related]
29. Common genetic variants on 3q28 contribute to non-small cell lung cancer susceptibility: evidence from 10 case-control studies.
Jin YX; Jiang GN; Zheng H; Duan L; Ding JA
Mol Genet Genomics; 2015 Apr; 290(2):573-84. PubMed ID: 25344291
[TBL] [Abstract][Full Text] [Related]
30. Lack of association between COX-2 8473T>C polymorphism and breast cancer risk: a meta-analysis.
Jiang J; Quan XF; Zhang L; Shen L; Zhang MX; Ma HH; Wang YC
Contemp Oncol (Pozn); 2014; 18(3):177-81. PubMed ID: 25520577
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 expression and association with skin cancer: A meta-analysis based on Chinese patients.
Shujiao L; Lilin H; Yong S
J Cancer Res Ther; 2016 Dec; 12(Supplement):C288-C290. PubMed ID: 28230039
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2 (COX-2) gene polymorphism in patients with differentiated thyroid carcinomas in the Turkish population.
Uçan B; Özbek M; Şahin M; Kızılgül M; Çakal E
Turk J Med Sci; 2017 Dec; 47(6):1848-1853. PubMed ID: 29306248
[TBL] [Abstract][Full Text] [Related]
33. The SNP rs931794 in 15q25.1 Is Associated with Lung Cancer Risk: A Hospital-Based Case-Control Study and Meta-Analysis.
Wang Q; Ke J; Song Q; Hu W; Lu X; Wang Z; Gong H; Xu T; Chen X; Xu B; Liu C; Sun Y; Gong Y; Yang Y; Zhu Y
PLoS One; 2015; 10(6):e0128201. PubMed ID: 26079375
[TBL] [Abstract][Full Text] [Related]
34. Asthma and the risk of lung cancer: a meta-analysis.
Qu YL; Liu J; Zhang LX; Wu CM; Chu AJ; Wen BL; Ma C; Yan XY; Zhang X; Wang DM; Lv X; Hou SJ
Oncotarget; 2017 Feb; 8(7):11614-11620. PubMed ID: 28086224
[TBL] [Abstract][Full Text] [Related]
35. A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation.
Moore AE; Young LE; Dixon DA
Oncogene; 2012 Mar; 31(12):1592-8. PubMed ID: 21822307
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 -1195G>A (rs689466) polymorphism and cancer susceptibility: an updated meta-analysis involving 50,672 subjects.
Wang Y; Jiang H; Liu T; Tang W; Ma Z
Int J Clin Exp Med; 2015; 8(8):12448-62. PubMed ID: 26550156
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of molecular epidemiology of human lung cancer. Report of a meeting. Oslo, Norway, August 9-12, 1998.
Haugen A; Harris CC
Lung Cancer; 1998 Dec; 22(3):255-63. PubMed ID: 10048479
[No Abstract] [Full Text] [Related]
38. Association between cyclooxygenase-2 (COX-2) 8473 T > C polymorphism and cancer risk: a meta-analysis and trial sequential analysis.
Li Q; Ma C; Zhang Z; Chen S; Zhi W; Zhang L; Zhang G; Shi L; Cao F; Ma T
BMC Cancer; 2018 Aug; 18(1):847. PubMed ID: 30143023
[TBL] [Abstract][Full Text] [Related]
39. COX-2 overexpression and -8473 T/C polymorphism in 3' UTR in non-small cell lung cancer.
Bhat IA; Rasool R; Qasim I; Masoodi KZ; Paul SA; Bhat BA; Ganaie FA; Aziz SA; Shah ZA
Tumour Biol; 2014 Nov; 35(11):11209-18. PubMed ID: 25113252
[TBL] [Abstract][Full Text] [Related]
40. Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review.
Jing L; Su L; Ring BZ
PLoS One; 2014; 9(6):e97522. PubMed ID: 24901479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
